What is the type of my study, case control or retrospective cohort?


6

130

January 27, 2023

Effectiveness of Paxlovid a retrospective study


5

184

January 11, 2023

Justification of sample size for the generation of a prediction model


7

439

January 11, 2023

Should we account for competing risk when estimating incidence rate?


3

223

January 5, 2023

Precisionbased sample size calculation for one survival curve


3

292

November 16, 2022

Conceptual question about survival analysis vs logistic regression: when is one more appropriate than the other?


16

10826

October 27, 2022

Background to PFS endpoint


19

5195

October 6, 2022

Method to obtain optimal cutoff point for survival outcomes


3

468

October 1, 2022

Could cardiovescular risk nomogram be supirior than the Framingham Risk Score? If so, what could be the reasons?


0

233

September 20, 2022

Elastic net model for nonlinear relationship?


2

1908

July 26, 2022

Intervention with early survival benefit, questionable long term harm


8

1588

May 26, 2022

Schoenfeld Residuals


1

1648

May 23, 2022

Comparing nonnested models on the same data


4

2663

May 13, 2022

Should I impute persontime before conducting proportional hazards analysis?


7

1445

May 8, 2022

Stratification on a variable involved in an interaction term


3

1192

May 4, 2022

Validation of cox model


4

3790

May 2, 2022

Cutpoint for Estimation of Prognostic value of a continuous Marker


5

1637

May 2, 2022

How should I compare crossing survival curves?


5

2932

April 28, 2022

Is logistic regression or survival analysis most appropriate in this case?


1

1070

April 28, 2022

Statistical power estimation for a timedependent covariate in Cox (proportional hazards) regression


0

986

April 19, 2022

Propensity score weighting and competing risks


2

1923

March 30, 2022

How to calculate number of events in each treatment arm given hazard ratio and CI?


2

1372

March 6, 2022

RMS Case Study in Cox Regression


1

13679

September 17, 2021

Hazard ratio plots with nonlinear & timevarying effects in R


28

29660

September 19, 2020

How to use RCS in mixed effects cox regression


3

2855

December 10, 2021

KaplanMeier: SE for absolute difference in timepoint survival


13

2747

October 30, 2021

How can I determined the best cutoff for survival ROC


1

1864

October 10, 2021

First RCT of Lopinavir–Ritonavir on SARSCoV2


38

15450

October 8, 2021

Overall survival vs diseasefree survival and other surrogate endpoints


2

4311

September 22, 2021

RMS Case Study in Parametric Survival Modeling


0

10460

September 17, 2021
